Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 27 Aug 20 424B3 Prospectus supplement
- 21 Aug 20 424B3 Prospectus supplement
- 12 Aug 20 424B3 Prospectus supplement
- 11 Aug 20 424B3 Prospectus supplement
- 5 Aug 20 424B3 Prospectus supplement
- 31 Jul 20 424B3 Prospectus supplement
- 28 Jul 20 424B3 Prospectus supplement
- 27 Jul 20 EFFECT Notice of effectiveness
- 23 Jul 20 F-1/A Registration statement (foreign) (amended)
- 22 Jul 20 FWP Free writing prospectus
-
21 Jul 20 F-1 Registration statement (foreign)
BNTX similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form F-1 of BioNTech SE of our report dated March 2, 2020, relating to the financial statements of Neon Therapeutics, Inc., which appears in Neon Therapeutics, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2019. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP |
Boston, Massachusetts |
July 21, 2020 |